← Open Payments lookup

AUDREY MCGINNIS: Open Payments

NPI 1275248817 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$334 in 18 payments from 7 companies in 2025. Trend: 2023 $229 · 2024 $499 · 2025 $334

Food & beverage: $334
CompanyPaymentsAmount
ABBVIE INC.5$101
Novo Nordisk Inc3$58
Lilly USA, LLC3$55
Amgen Inc.3$44
PFIZER INC.2$43
GlaxoSmithKline, LLC.1$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$15

Products named: QULIPTA, Wegovy, MOUNJARO, UBRELVY, OTEZLA, PREVNAR 20, ELIQUIS, TRELEGY ELLIPTA.

Industry payments across TX — which companies pay providers there.